Year: 2019

Crocus Technology Unveils 2nd Gen TMR Linear Sensor with Unparalleled Temperature Stability

March 19, 2019

Crocus Technology Inc., a leading supplier of disruptive Tunnel Magneto-Resistance (TMR) sensors, today announces the CT100 device, an advanced, high-performance linear (1D) magnetic sensor based on Crocus’ patented and unique TMR- based technology. The CT100 has best-in-class performance across...

Read More

Twist Bioscience Showcases Next-Generation Sequencing Solutions at the 2019 Advances in Genome Biology and Technology Meeting

February 28, 2019

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the availability of new product solutions for its Twist Human Core Exome Kit and Twist...

Read More

Selecta Biosciences Announces Pricing of Public Offering of Common Stock

January 23, 2019

Selecta Biosciences, Inc. (Nasdaq: SELB) (“Selecta”), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune tolerance platform technology, ImmTOR (SVP Rapamycin), today announced the pricing of an underwritten public offering of 20,000,000 shares...

Read More

Natron Energy Announces Strategic Investment by Chevron Technology Ventures

January 14, 2019

Natron Energy, a developer and provider of disruptive new battery products using Prussian Blue electrode chemistry, has closed a strategic investment by Chevron Technology Ventures (CTV) to support the development of stationary energy storage systems for demand charge management...

Read More

SQZ Biotech Strengthens Leadership Team with Appointment of Chief Medical Officer

January 3, 2019

Industry veteran, Oliver Rosen, MD, to join executive team as SQZ prepares to enter the clinic SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the appointment of Oliver Rosen, MD, as...

Read More